Your browser doesn't support javascript.
loading
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.
Haikala, Heidi M; Anttila, Johanna M; Marques, Elsa; Raatikainen, Tiina; Ilander, Mette; Hakanen, Henna; Ala-Hongisto, Hanna; Savelius, Mariel; Balboa, Diego; Von Eyss, Bjoern; Eskelinen, Vilja; Munne, Pauliina; Nieminen, Anni I; Otonkoski, Timo; Schüler, Julia; Laajala, Teemu D; Aittokallio, Tero; Sihto, Harri; Mattson, Johanna; Heikkilä, Päivi; Leidenius, Marjut; Joensuu, Heikki; Mustjoki, Satu; Kovanen, Panu; Eilers, Martin; Leverson, Joel D; Klefström, Juha.
Afiliación
  • Haikala HM; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Anttila JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 360 Longwood Ave, 02215, Boston, MA, USA.
  • Marques E; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Raatikainen T; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Ilander M; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Hakanen H; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Ala-Hongisto H; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Savelius M; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Balboa D; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Von Eyss B; Research Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Eskelinen V; Leibniz Institute of Age Research, Fritz Lipmann Institute e.V, Beutenbergstraße 11, 07745, Jena, Germany.
  • Munne P; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Nieminen AI; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
  • Otonkoski T; Department of Biosciences and Institute of Biotechnology, University of Helsinki, Viikinkaari 5, 00790, Helsinki, Finland.
  • Schüler J; Research Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Laajala TD; Oncotest GmbH, (Now part of Charles River Laboratories Inc, 251 Ballardvale St, Wilmington, MA 01887, USA), Freiburg, Germany.
  • Aittokallio T; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.
  • Sihto H; Department of Mathematics and Statistics, University of Turku, Vesilinnantie 5, 20500, Turku, Finland.
  • Mattson J; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.
  • Heikkilä P; Department of Mathematics and Statistics, University of Turku, Vesilinnantie 5, 20500, Turku, Finland.
  • Leidenius M; Research Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.
  • Joensuu H; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland.
  • Mustjoki S; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland.
  • Kovanen P; Department of Pathology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 3, 00290, Helsinki, Finland.
  • Eilers M; Breast Surgery Unit, Helsinki University Hospital, Kasarmikatu 11-13, 00290, Helsinki, Finland.
  • Leverson JD; Research Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.
  • Klefström J; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland.
Nat Commun ; 10(1): 932, 2019 02 20.
Article en En | MEDLINE | ID: mdl-30787321
ABSTRACT
The original version of this Article contained an error in Fig. 7. In panel b, the survival curves were shifted relative to the y axis. This error has been corrected in both the PDF and HTML versions of the Article.
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Finlandia